TEVA logo

TEVA Cash from financing

annual CFF:

-$1.79B+$122.00M(+6.38%)
December 31, 2024

Summary

  • As of today (May 29, 2025), TEVA annual cash flow from financing activities is -$1.79 billion, with the most recent change of +$122.00 million (+6.38%) on December 31, 2024.
  • During the last 3 years, TEVA annual CFF has risen by +$381.00 million (+17.54%).
  • TEVA annual CFF is now -107.10% below its all-time high of $25.22 billion, reached on December 31, 2016.

Performance

TEVA Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

quarterly CFF:

-$1.74B-$1.07B(-158.75%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA quarterly cash flow from financing activities is -$1.74 billion, with the most recent change of -$1.07 billion (-158.75%) on March 31, 2025.
  • Over the past year, TEVA quarterly CFF has dropped by -$1.59 billion (-1054.97%).
  • TEVA quarterly CFF is now -106.87% below its all-time high of $25.37 billion, reached on September 30, 2016.

Performance

TEVA quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

TTM CFF:

-$3.38B-$1.59B(-88.94%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA TTM cash flow from financing activities is -$3.38 billion, with the most recent change of -$1.59 billion (-88.94%) on March 31, 2025.
  • Over the past year, TEVA TTM CFF has dropped by -$2.03 billion (-149.19%).
  • TEVA TTM CFF is now -111.05% below its all-time high of $30.63 billion, reached on September 30, 2016.

Performance

TEVA TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TEVA Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.4%-1055.0%-149.2%
3 y3 years+17.5%-10000.0%-101.8%
5 y5 years+7.0%-149.1%-38.9%

TEVA Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-20.4%+17.5%<-9999.0%at low-165.0%at low
5 y5-year-20.4%+17.5%<-9999.0%at low-165.0%at low
alltimeall time-107.1%+68.8%-106.9%+30.4%-111.0%+44.3%

TEVA Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$1.74B(+158.8%)
-$3.38B(+88.9%)
Dec 2024
-$1.79B(-6.4%)
-$674.00M(<-9900.0%)
-$1.79B(+5.8%)
Sep 2024
-
$0.00(-100.0%)
-$1.69B(-25.4%)
Jun 2024
-
-$966.00M(+539.7%)
-$2.27B(+67.1%)
Mar 2024
-
-$151.00M(-73.8%)
-$1.36B(-29.0%)
Dec 2023
-$1.91B(+28.6%)
-$576.00M(0.0%)
-$1.91B(-6.6%)
Sep 2023
-
-$576.00M(+947.3%)
-$2.05B(+7.1%)
Jun 2023
-
-$55.00M(-92.2%)
-$1.91B(-12.9%)
Mar 2023
-
-$706.00M(-0.7%)
-$2.19B(+47.6%)
Dec 2022
-$1.49B(-31.5%)
-$711.00M(+61.6%)
-$1.49B(+16.4%)
Sep 2022
-
-$440.00M(+30.2%)
-$1.28B(-36.6%)
Jun 2022
-
-$338.00M(<-9900.0%)
-$2.01B(+20.1%)
Mar 2022
-
$2.00M(-100.4%)
-$1.68B(-22.8%)
Dec 2021
-$2.17B(+15.2%)
-$501.00M(-57.4%)
-$2.17B(+20.9%)
Sep 2021
-
-$1.18B(>+9900.0%)
-$1.80B(+7.2%)
Jun 2021
-
-$1.00M(-99.8%)
-$1.68B(-0.1%)
Mar 2021
-
-$493.00M(+294.4%)
-$1.68B(-11.0%)
Dec 2020
-$1.89B(-2.1%)
-$125.00M(-88.2%)
-$1.89B(-5.8%)
Sep 2020
-
-$1.06B(>+9900.0%)
-$2.00B(-16.8%)
Jun 2020
-
-$3.00M(-99.6%)
-$2.40B(-1.3%)
Mar 2020
-
-$700.00M(+190.5%)
-$2.44B(+26.5%)
Dec 2019
-$1.93B(-42.5%)
-$241.00M(-83.5%)
-$1.93B(-11.8%)
Sep 2019
-
-$1.46B(+4074.3%)
-$2.18B(+52.9%)
Jun 2019
-
-$35.00M(-81.5%)
-$1.43B(-1.4%)
Mar 2019
-
-$189.00M(-62.1%)
-$1.45B(-56.8%)
Dec 2018
-$3.35B(-41.7%)
-$499.00M(-29.2%)
-$3.35B(-37.5%)
Sep 2018
-
-$705.00M(+1158.9%)
-$5.36B(-2.2%)
Jun 2018
-
-$56.00M(-97.3%)
-$5.48B(-9.8%)
Mar 2018
-
-$2.09B(-16.6%)
-$6.07B(+5.6%)
Dec 2017
-$5.75B(-122.8%)
-$2.51B(+203.8%)
-$5.75B(+45.8%)
Sep 2017
-
-$825.00M(+26.7%)
-$3.94B(-117.7%)
Jun 2017
-
-$651.00M(-63.2%)
$22.25B(-4.0%)
Mar 2017
-
-$1.77B(+152.2%)
$23.18B(-8.1%)
Dec 2016
$25.22B(+424.8%)
-$701.00M(-102.8%)
$25.22B(-17.7%)
Sep 2016
-
$25.37B(+8993.9%)
$30.63B(+634.4%)
Jun 2016
-
$279.00M(+4.5%)
$4.17B(-16.2%)
Mar 2016
-
$267.00M(-94.3%)
$4.98B(+3.6%)
Dec 2015
$4.80B(-302.3%)
$4.71B(-532.6%)
$4.80B(-1055.3%)
Sep 2015
-
-$1.09B(-200.3%)
-$503.00M(-295.0%)
Jun 2015
-
$1.09B(+1068.8%)
$258.00M(-115.7%)
Mar 2015
-
$93.00M(-115.7%)
-$1.65B(-30.6%)
Dec 2014
-$2.38B(-38.8%)
-$593.00M(+80.2%)
-$2.38B(-1.1%)
Sep 2014
-
-$329.00M(-59.8%)
-$2.40B(+3.1%)
Jun 2014
-
-$819.00M(+29.2%)
-$2.33B(+3.1%)
Mar 2014
-
-$634.00M(+2.4%)
-$2.26B(-41.9%)
Dec 2013
-$3.88B(+131.4%)
-$619.00M(+141.8%)
-$3.88B(+29.5%)
Sep 2013
-
-$256.00M(-65.8%)
-$3.00B(-9.5%)
Jun 2013
-
-$748.00M(-66.9%)
-$3.31B(-0.4%)
Mar 2013
-
-$2.26B(-949.6%)
-$3.33B(+98.2%)
Dec 2012
-$1.68B(-150.3%)
$266.00M(-146.7%)
-$1.68B(-178.1%)
Sep 2012
-
-$570.00M(-25.1%)
$2.15B(-37.1%)
Jun 2012
-
-$761.00M(+24.1%)
$3.42B(-2.2%)
Mar 2012
-
-$613.00M(-115.0%)
$3.49B(+4.7%)
DateAnnualQuarterlyTTM
Dec 2011
$3.34B(+482.2%)
$4.09B(+486.2%)
$3.34B(-351.0%)
Sep 2011
-
$698.00M(-202.0%)
-$1.33B(-40.4%)
Jun 2011
-
-$684.00M(-11.2%)
-$2.23B(>+9900.0%)
Mar 2011
-
-$770.00M(+34.4%)
-$22.00M(-103.8%)
Dec 2010
$573.00M(-125.3%)
-$573.00M(+180.9%)
$573.00M(-38.6%)
Sep 2010
-
-$204.00M(-113.4%)
$933.00M(+288.8%)
Jun 2010
-
$1.52B(-971.4%)
$240.00M(-109.9%)
Mar 2010
-
-$175.00M(-17.8%)
-$2.42B(+6.7%)
Dec 2009
-$2.27B(-266.8%)
-$213.00M(-76.3%)
-$2.27B(+2444.9%)
Sep 2009
-
-$897.00M(-20.7%)
-$89.00M(-112.3%)
Jun 2009
-
-$1.13B(+4612.5%)
$724.00M(-40.8%)
Mar 2009
-
-$24.00M(-101.2%)
$1.22B(-10.0%)
Dec 2008
$1.36B(-475.1%)
$1.96B(-2436.9%)
$1.36B(-278.4%)
Sep 2008
-
-$84.00M(-86.7%)
-$761.00M(-17.3%)
Jun 2008
-
-$633.00M(-665.2%)
-$920.00M(+221.7%)
Mar 2008
-
$112.00M(-171.8%)
-$286.00M(-21.0%)
Dec 2007
-$362.00M(-117.9%)
-$156.00M(-35.8%)
-$362.00M(-31.9%)
Sep 2007
-
-$243.00M(<-9900.0%)
-$531.30M(-1.9%)
Jun 2007
-
$1.00M(-97.2%)
-$541.80M(+3.2%)
Mar 2007
-
$36.00M(-111.1%)
-$525.00M(-125.9%)
Dec 2006
$2.02B(-746.6%)
-$325.30M(+28.3%)
$2.02B(-25.0%)
Sep 2006
-
-$253.50M(-1524.2%)
$2.70B(-3.5%)
Jun 2006
-
$17.80M(-99.3%)
$2.80B(+8.3%)
Mar 2006
-
$2.58B(+636.9%)
$2.58B(-924.8%)
Dec 2005
-$313.00M(-136.7%)
$350.80M(-323.9%)
-$313.00M(-59.1%)
Sep 2005
-
-$156.70M(-20.6%)
-$764.40M(+6.9%)
Jun 2005
-
-$197.40M(-36.3%)
-$714.80M(+31.2%)
Mar 2005
-
-$309.70M(+207.9%)
-$544.80M(-163.9%)
Dec 2004
$852.00M(+2778.4%)
-$100.60M(-6.1%)
$852.00M(-13.6%)
Sep 2004
-
-$107.10M(+290.9%)
$986.60M(-8.7%)
Jun 2004
-
-$27.40M(-102.5%)
$1.08B(-2.5%)
Mar 2004
-
$1.09B(+3097.4%)
$1.11B(+3643.6%)
Dec 2003
$29.60M(-91.2%)
$34.00M(-361.5%)
$29.60M(-93.1%)
Sep 2003
-
-$13.00M(<-9900.0%)
$428.20M(+0.8%)
Jun 2003
-
$0.00(-100.0%)
$424.70M(+7.4%)
Mar 2003
-
$8.60M(-98.0%)
$395.50M(+17.2%)
Dec 2002
$337.50M(+26.5%)
$432.60M(-2721.8%)
$337.50M(-409.7%)
Sep 2002
-
-$16.50M(-43.5%)
-$108.98M(-131.5%)
Jun 2002
-
-$29.20M(-40.9%)
$345.47M(+1.9%)
Mar 2002
-
-$49.40M(+255.8%)
$339.11M(+27.1%)
Dec 2001
$266.72M(+0.4%)
-$13.88M(-103.2%)
$266.72M(-4.9%)
Sep 2001
-
$437.95M(-1331.5%)
$280.60M(-278.3%)
Jun 2001
-
-$35.56M(-70.8%)
-$157.35M(+29.2%)
Mar 2001
-
-$121.79M
-$121.79M
Dec 2000
$265.71M(+75.4%)
-
-
Dec 1999
$151.48M(+174.6%)
-
-
Dec 1998
$55.16M(-141.0%)
-
-
Dec 1997
-$134.50M(-202.5%)
-
-
Dec 1996
$131.20M(+226.4%)
-
-
Dec 1995
$40.20M(+0.8%)
-
-
Dec 1994
$39.90M(-10.5%)
-
-
Dec 1993
$44.60M(+85.8%)
-
-
Dec 1992
$24.00M(-31.8%)
-
-
Dec 1991
$35.20M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual cash flow from financing activities?
  • What is the all time high annual CFF for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual CFF year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly CFF year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM CFF year-on-year change?

What is Teva Pharmaceutical Industries Limited annual cash flow from financing activities?

The current annual CFF of TEVA is -$1.79B

What is the all time high annual CFF for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual cash flow from financing activities is $25.22B

What is Teva Pharmaceutical Industries Limited annual CFF year-on-year change?

Over the past year, TEVA annual cash flow from financing activities has changed by +$122.00M (+6.38%)

What is Teva Pharmaceutical Industries Limited quarterly cash flow from financing activities?

The current quarterly CFF of TEVA is -$1.74B

What is the all time high quarterly CFF for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly cash flow from financing activities is $25.37B

What is Teva Pharmaceutical Industries Limited quarterly CFF year-on-year change?

Over the past year, TEVA quarterly cash flow from financing activities has changed by -$1.59B (-1054.97%)

What is Teva Pharmaceutical Industries Limited TTM cash flow from financing activities?

The current TTM CFF of TEVA is -$3.38B

What is the all time high TTM CFF for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM cash flow from financing activities is $30.63B

What is Teva Pharmaceutical Industries Limited TTM CFF year-on-year change?

Over the past year, TEVA TTM cash flow from financing activities has changed by -$2.03B (-149.19%)
On this page